Publications

Chuansumrit A, Ruchutrakul T, Sirachainan N, Kitpoka P, Panuwannakorn M, Panburana P, Suwannuraks M, Sri-Udomporn N, Kijkunasathian C, Jaovisidha S, Utamakul C, Natesirinilkul R, Pongtanakul B, Traivaree C, Komvilaisak P, Suwantaroj E, Sosothikul D, Angchaisuksiri P, Rojnuckarin P. National strategic advocacy to manage patients with inherited bleeding disorders in low and lower-middle income countries. Expert Rev Hematol. 2023 Dec;16(12):1063-1076.

2.8

Kenet G, Young G, Chuansumrit A, Matsushita T, Yadav V, Zak M, Male C. The immunogenicity, safety, and efficacy of N8-GP in previously untreated patients with severe hemophilia A: pathfinder6 end-of-trial results. J Thromb Haemost. 2023 Nov;21(11):3109-3116.

10.4

Tanratana P, Sachetto ATA, Mast AE, Mackman N. An anti-tissue factor pathway inhibitor antibody increases tissue factor activity in extracellular vesicles isolated from human plasma. Res Pract Thromb Haemost. 2023 Nov 26;8(1):102275. doi: 10.1016/j.rpth.2023.102275.

4.6

Vasaruchapong S, Woratanarat P, Patathong T, Woratanarat T, Jaovisidha S, Angsanunsukh C. The efficacy of pediatric elbow radiographic guidance in diagnosis of lateral humeral condyle fracture. PLoS One. 2024 Mar 15;19(3):e0300014. doi: 10.1371/journal.pone.0300014.

3.7

Chuansumrit A, Songdej D, Sirachainan N, Kadegasem P, Saisawat P, Sungkarat W, Kempka K, Tungbubpha N. Efficacy and Safety of a Dispersible Tablet of GPO-Deferasirox Monotherapy among Children with Transfusion-Dependent Thalassemia and Iron Overload. Hemoglobin. 2024 Jan;48(1):47-55.

0.822

Seanoon K, Kitiyanant V, Payongsri P, Sirachainan N, Angchaisuksiri P, Chuansumrit A, Hongeng S, Tanratana P. Site-directed mutagenesis of tissue factor pathway inhibitor-binding exosite D60A on factor VII results in a new factor VII variant with lower coagulant activity. Res Pract Thromb Haemost. 2024 Jan 2;8(1):102309. doi: 10.1016/j.rpth.2023.102309.

4.6

Chuansumrit A, Youttananukorn W, Sirachainan N, Natesirinilkul R, Ruchutrakool T. Direct data transfer of people with hereditary bleeding disorders from the Thai haemophilia treatment centre registry to the Annual Global Survey of the World Federation of Hemophilia. Haemophilia. 2024 Jan;30(1):245-248.

3.9

Peyvandi F, Angchaisuksiri P, Reiser T. ISTH's new strategic plan 2024-2028: A transformative journey toward shaping the future of thrombosis and hemostasis. J Thromb Haemost. 2024 Apr 26:S1538-7836(24)00233-2. doi: 10.1016/j.jtha.2024.04.013.

10.4

Maneekhiew S, Kovitwanawong N, Raweekul S, Kijkunasathian C, Panuwannakorn M, Uampornvanich P, Chuansumrit A, Wongwerawattanakoon P, Sirachainan N. Comparison between natural rubber knee support and sponge knee support on the protection of knee joint: A crossover randomized controlled study among patients with bleeding disorders. Health Sci Rep. 2024 Apr 1;7(4):e2003. doi: 10.1002/hsr2.2003.

1.945

Khongphithakskul P, Tangbubpha N, Khlangtan T, Kadegasem P, Songdej D, Sirachainan N. One-step amplification refractory mutation system-PCR/high-resolution melting curve assay for carrier detection of red blood cell membranopathy caused by common SPTB mutations. Int J Lab Hematol. 2024 Apr;46(2):375-382.

3.0

Angchaisuksiri P, Amurao-Abiera M, Chou SC, Chewcharat P, Chozie NA, Gomez R, Leng TS, Lin PC, Mai NT, Muda Z, Seth T, Sosothikul D, Siu-Ming Wong R. Haemophilia care in Asia: Learning from clinical practice in some Asian countries. Haemophilia. 2024 May;30(3):609-616.

3.9

Rajpurkar M, Rosovsky RP, Williams S, Chan AKC, van Ommen CH, Faustino EVS, White M, Parikh M, Sirachainan N, Biss T, Goldenberg NA. Considerations for instituting pediatric pulmonary embolism response teams: A tool kit. Thromb Res. 2024 Apr;236:97-107

10.4

Pongphitcha P, Sasanakul W, Kadegasem P, Songdej D, Limwongse C, Amesbutr M, Jaovisidha S, Chuansumrit A, Sirachainan N. Alleviated bleeding phenotypes in a child with severe haemophilia A and thalassemia disease. Haemophilia. 2024 May 23. doi: 10.1111/hae.15041.

3.9